UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society

Zhang, H; Deng, M; Lin, P; Liu, J; Liu, C; Strohl, WR; Wang, S; (2018) Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society. Antibody Therapeutics , 1 (2) pp. 65-74. 10.1093/abt/tby009. Green open access

[thumbnail of Zhang_Frontiers and Opportunities. Highlights of the 2nd Annual Conference of the Chinese Antibody Society_VoR.pdf]
Preview
Text
Zhang_Frontiers and Opportunities. Highlights of the 2nd Annual Conference of the Chinese Antibody Society_VoR.pdf - Published Version

Download (14MB) | Preview

Abstract

The Chinese Antibody Society (CAS) convened the second annual conference in Cambridge, MA, USA on 29 April 2018. More than 600 members from around the world attended the meeting. Invited speakers discussed the latest advancements in therapeutic antibodies with an emphasis on the progress made in China. The meeting covered a vast variety of topics including the current status of therapeutic antibodies, the progress of immuno-oncology, and biosimilars in China. The conference presentations also included the development of several novel antibodies such as antibodies related to weight loss, T-cell receptor-mimicking antibodies that target intracellular antigens, and tumor-targeting antibodies that utilize both innate and adaptive immune pathways. At the meeting, the CAS announced the launch of its official journal-Antibody Therapeutics-in collaboration with Oxford University Press. The conference was concluded by a panel discussion on how to bring a therapeutic drug developed in China to the USA for clinical trials.

Type: Article
Title: Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/abt/tby009
Publisher version: https://doi.org/10.1093/abt/tby009
Language: English
Additional information: © The Author(s) 2018. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: CAR T cells, Chinese Antibody Society, antibody therapeutics, biosimilars, bispecific antibodies
UCL classification: UCL
UCL > Provost and Vice Provost Offices > UCL BEAMS
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science
UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering
URI: https://discovery.ucl.ac.uk/id/eprint/10064452
Downloads since deposit
71Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item